JNPMEDI unveils the 'Maven DCT Suite', a 'distributed clinical trial' platform at KiMES 2023.

JNPMEDI, a medical data platform company, announced that it will participate in the 38th Korea International Medical & Hospital Equipment Show (KIMES 2023) held at COEX, Seoul from March 23 to 26.

At this KIMES 2023, JNPMEDI will operate an independent booth and introduce the 'Maven Clinical Cloud' solution required for decentralized clinical trials.

In addition, services that enable patient-centered remote clinical trials without visiting medical institutions through DCT-related functions such as eConsent, Identify, and eCOA (Clinical Outcome Assessment) of clinical trial subjects will also be introduced. .

JNPMEDI's major service, the Maven Clinical Cloud solution, has differentiated capabilities compared to its competitors, such as preemptively securing decentralized clinical trials(DCT) in line with the non-face-to-face trend.

An official from JNPMEDI said, "Recently, we have expanded the business development team by recruiting experts in the clinical industry."

JNPMEDI, a medical data platform company established in 2020, has developed its own clinical trial data management platform Maven Clinical Cloud Solution that can be applied to various medical areas such as pharmaceuticals, bio, medical devices, and digital treatments.